Discovery of pyrazolopyrrolidinones as potent, broad-spectrum inhibitors of Leishmania infection
{{output}}
Introduction: Leishmaniasis is a parasitic disease that affects more than 1 million people worldwide annually, predominantly in resource-limited settings. The challenge in compound development is to exhibit potent activity agains... ...
